These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 19154704)

  • 21. Factors to consider in the use of stem cells for pharmaceutic drug development and for chemical safety assessment.
    Trosko JE; Chang CC
    Toxicology; 2010 Mar; 270(1):18-34. PubMed ID: 19948204
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Auditing drug metabolism protocols, data, and reports.
    Lucas G; Walls S
    Qual Assur; 1994 Jun; 3(2):193-7. PubMed ID: 7804636
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Applications of emerging technologies in toxicology and safety assessment.
    Reynolds VL
    Int J Toxicol; 2005; 24(3):135-7. PubMed ID: 16040564
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of pharmacology data and the prediction of adverse drug reactions and off-target effects from chemical structure.
    Bender A; Scheiber J; Glick M; Davies JW; Azzaoui K; Hamon J; Urban L; Whitebread S; Jenkins JL
    ChemMedChem; 2007 Jun; 2(6):861-73. PubMed ID: 17477341
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alternative strategies in drug development: clinical pharmacological aspects.
    Kuhlmann J
    Int J Clin Pharmacol Ther; 1999 Dec; 37(12):575-83. PubMed ID: 10599949
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Application of genomics in preclinical drug safety evaluation.
    Lord PG; Nie A; McMillian M
    Basic Clin Pharmacol Toxicol; 2006 Jun; 98(6):537-46. PubMed ID: 16700814
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predictive computational toxicology to support drug safety assessment.
    Valerio LG
    Methods Mol Biol; 2013; 930():341-54. PubMed ID: 23086849
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anticancer Drug Development: The Way Forward.
    Connors T
    Oncologist; 1996; 1(3):180-181. PubMed ID: 10387985
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Early prediction of drug metabolism and toxicity: systems biology approach and modeling.
    Bugrim A; Nikolskaya T; Nikolsky Y
    Drug Discov Today; 2004 Feb; 9(3):127-35. PubMed ID: 14960390
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Emerging technologies and challenges for better and safer drugs.
    Theodosiou M; Amir-Aslani A; Mégarbane B
    Biotechnol Lett; 2014 Apr; 36(4):677-84. PubMed ID: 24243233
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quantitative proteomics for drug toxicity.
    Gao Y; Holland RD; Yu LR
    Brief Funct Genomic Proteomic; 2009 Mar; 8(2):158-66. PubMed ID: 19351682
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Application of emerging technologies in toxicology and safety assessment: regulatory perspectives.
    Leighton JK
    Int J Toxicol; 2005; 24(3):153-5. PubMed ID: 16040567
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The concept of multispecies testing in industrial toxicology.
    Zbinden G
    Regul Toxicol Pharmacol; 1993 Feb; 17(1):85-94. PubMed ID: 8441831
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Toxicogenomics in drug discovery: from preclinical studies to clinical trials.
    Yang Y; Blomme EA; Waring JF
    Chem Biol Interact; 2004 Nov; 150(1):71-85. PubMed ID: 15522262
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Accurate prediction of human drug toxicity: a major challenge in drug development.
    Li AP
    Chem Biol Interact; 2004 Nov; 150(1):3-7. PubMed ID: 15522257
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Current challenges in the evaluation of cardiac safety during drug development: translational medicine meets the Critical Path Initiative.
    Piccini JP; Whellan DJ; Berridge BR; Finkle JK; Pettit SD; Stockbridge N; Valentin JP; Vargas HM; Krucoff MW;
    Am Heart J; 2009 Sep; 158(3):317-26. PubMed ID: 19699852
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 3D-MEDNEs: an alternative "in silico" technique for chemical research in toxicology. 2. quantitative proteome-toxicity relationships (QPTR) based on mass spectrum spiral entropy.
    Cruz-Monteagudo M; González-Díaz H; Borges F; Dominguez ER; Cordeiro MN
    Chem Res Toxicol; 2008 Mar; 21(3):619-32. PubMed ID: 18257557
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Are multimetabolite methods fit-for-purpose for supporting toxicology studies?
    Smith G
    Bioanalysis; 2011 Dec; 3(24):2701-4. PubMed ID: 22185267
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The practice of pre-marketing safety assessment in drug development.
    Chuang-Stein C; Xia HA
    J Biopharm Stat; 2013; 23(1):3-25. PubMed ID: 23331218
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Drug safety testing paradigm, current progress and future challenges: an overview.
    Ahuja V; Sharma S
    J Appl Toxicol; 2014 Jun; 34(6):576-94. PubMed ID: 24777877
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.